News from the AGA
News from the AGA
Top AGA Community patient cases
Physicians with difficult patient scenarios seek advice from colleagues about therapy and disease management options, best practices, and...
News from the AGA
Prior authorization and step therapy: My visit to Capitol Hill
As a member of the AGA Congressional Advocates Program, I received training and support in visiting Capitol Hill, discussing specific legislation...
News from the AGA
AGA remembers Dr. Henry T. Lynch
Dr. Henry T. Lynch provided the first complete description of hereditary nonpolyposis colorectal cancer, a form of colon cancer eventually renamed...
News from the AGA
Top AGA Community patient cases
Physicians with difficult patient scenarios bring their questions to the AGA Community to seek advice from colleagues about therapy and disease...
News from the AGA
Remember the AGA Research Foundation in your will or living trust
What if all you had to do to ensure that the AGA Research Foundation can have an impact for years to come is to write a simple sentence? Sound...
News from the AGA
Dr. Younossi presents at congressional briefing on International NASH Day
He called upon Congress to help educate policymakers on the increasing burden of NASH and to take steps to prevent its increase, including more...
News from the AGA
AGA journals select new editorial fellows
The journals are pleased to announce their 2019-2020 editorial fellows.
News from the AGA
Inside AGA’s meeting with FDA on fecal microbiota transplantation
AGA raised concerns about patient access to whole-stool FMT being restricted or eliminated once drugs containing live microbials are FDA approved...
News from the AGA
Physician innovator working to bring new tech to patients, thanks to AGA funding
When Dr. Ashish Nimgaonkar received his funding from the AGA Research Foundation in 2014, he was able to focus on developing a technology that...
News from the AGA
Washington makes low drug prices a priority
The House of Representatives passed two bills aimed at speeding up the development of generics and biosimilars while the Trump administration...